|
Sign In to gain access to subscriptions and/or personal tools.
|
Multiple Sclerosis, Vol. 5, No. 2,
101-104 (1999)
DOI: 10.1177/135245859900500206
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
D Matusevicius
Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
P Kivisäkk
Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
B He
Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
N Kostulas
Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
V Özenci
Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
S Fredrikson
Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
H Link
Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Myelin-directed autoimmunity is considered to play a key role in the pathogenesis of multiple sclerosis (MS). Increased production of both pro- and anti-inflammatory cytokines is a common finding in MS. Interleukin-17 (IL-17) is a recently described cytokine produced in humans almost exclusively by activated memory T cells, which can induce the production of proinflammatory cytokines and chemokines from parenchymal cells and macrophages. In situ hybridisation with synthetic oligonucleotide probes was adopted to detect and enumerate IL-17 mRNA expressing mononuclear cells (MNC) in blood and cerebrospinal fluid (CSF) from patients with MS and control individuals. Numbers of IL-17 mRNA expressing blood MNC were higher in patients with MS and acute aseptic meningoencephalitis (AM) compared to healthy individuals. Higher numbers of IL-17 mRNA expressing blood MNC were detected in MS patients examined during clinical exacerbation compared to remission. Patients with MS had higher numbers of IL-17 mRNA expressing MNC in CSF compared to blood. This increase in numbers of IL-17 mRNA expressing MNC in CSF was not observed in patients with AM. Our results thus demonstrate increased numbers of IL-17 mRNA expressing MNC in MS with higher numbers in CSF than blood, and with the highest numbers in blood during clinical exacerbations.
Key Words: IL-17 • multiple sclerosis • aseptic meningoencephalitis • autoimmunity
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D. E. Elliott, A. Metwali, J. Leung, T. Setiawan, A. M. Blum, M. N. Ince, L. E. Bazzone, M. J. Stadecker, J. F. Urban Jr., and J. V. Weinstock
Colonization with Heligmosomoides polygyrus Suppresses Mucosal IL-17 Production
J. Immunol.,
August 15, 2008;
181(4):
2414 - 2419.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Mills, L. F. Thompson, C. Mueller, A. T. Waickman, S. Jalkanen, J. Niemela, L. Airas, and M. S. Bynoe
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis
PNAS,
July 8, 2008;
105(27):
9325 - 9330.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Y. Yue, A. Merchant, C. M. Kovacs, M. Loutfy, D. Persad, and M. A. Ostrowski
Virus-Specific Interleukin-17-Producing CD4+ T Cells Are Detectable in Early Human Immunodeficiency Virus Type 1 Infection
J. Virol.,
July 1, 2008;
82(13):
6767 - 6771.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Serada, M. Fujimoto, M. Mihara, N. Koike, Y. Ohsugi, S. Nomura, H. Yoshida, T. Nishikawa, F. Terabe, T. Ohkawara, et al.
IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
PNAS,
July 1, 2008;
105(26):
9041 - 9046.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Krakauer, P Sorensen, M Khademi, T Olsson, and F Sellebjerg
Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-{beta} treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression
Multiple Sclerosis,
June 1, 2008;
14(5):
622 - 630.
[Abstract]
[PDF]
|
|
|
|
|
|
|
X. Zhang, J. Jin, X. Peng, V. S. Ramgolam, and S. Markovic-Plese
Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes
J. Immunol.,
May 15, 2008;
180(10):
6988 - 6996.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Carlson, M. Kroenke, P. Rao, T. E. Lane, and B. Segal
The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease
J. Exp. Med.,
April 14, 2008;
205(4):
811 - 823.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. W. Lim, J. Lee, P. Hillsamer, and C. H. Kim
Human Th17 Cells Share Major Trafficking Receptors with Both Polarized Effector T Cells and FOXP3+ Regulatory T Cells
J. Immunol.,
January 1, 2008;
180(1):
122 - 129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Tzartos, M. A. Friese, M. J. Craner, J. Palace, J. Newcombe, M. M. Esiri, and L. Fugger
Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
Am. J. Pathol.,
January 1, 2008;
172(1):
146 - 155.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Moisan, R. Grenningloh, E. Bettelli, M. Oukka, and I-C. Ho
Ets-1 is a negative regulator of Th17 differentiation
J. Exp. Med.,
November 26, 2007;
204(12):
2825 - 2835.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Peng, G. Han, H. Shao, Y. Wang, H. J. Kaplan, and D. Sun
Characterization of IL-17+ Interphotoreceptor Retinoid-Binding Protein-Specific T Cells in Experimental Autoimmune Uveitis
Invest. Ophthalmol. Vis. Sci.,
September 1, 2007;
48(9):
4153 - 4161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Annunziato, L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Fili, S. Ferri, F. Frosali, et al.
Phenotypic and functional features of human Th17 cells
J. Exp. Med.,
August 6, 2007;
204(8):
1849 - 1861.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Thakker, M. W. Leach, W. Kuang, S. E. Benoit, J. P. Leonard, and S. Marusic
IL-23 Is Critical in the Induction but Not in the Effector Phase of Experimental Autoimmune Encephalomyelitis
J. Immunol.,
February 15, 2007;
178(4):
2589 - 2598.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. R. Gocke, P. D. Cravens, L.-H. Ben, R. Z. Hussain, S. C. Northrop, M. K. Racke, and A. E. Lovett-Racke
T-bet Regulates the Fate of Th1 and Th17 Lymphocytes in Autoimmunity
J. Immunol.,
February 1, 2007;
178(3):
1341 - 1348.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. H. Hofstetter, K. V. Toyka, M. Tary-Lehmann, and P. V. Lehmann
Kinetics and Organ Distribution of IL-17-Producing CD4 Cells in Proteolipid Protein 139-151 Peptide-Induced Experimental Autoimmune Encephalomyelitis of SJL Mice
J. Immunol.,
February 1, 2007;
178(3):
1372 - 1378.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. C. Axtell, L. Xu, S. R. Barnum, and C. Raman
CD5-CK2 Binding/Activation-Deficient Mice Are Resistant to Experimental Autoimmune Encephalomyelitis: Protection Is Associated with Diminished Populations of IL-17-Expressing T Cells in the Central Nervous System
J. Immunol.,
December 15, 2006;
177(12):
8542 - 8549.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Rahman, A. Yamasaki, J. Yang, L. Shan, A. J. Halayko, and A. S. Gounni
IL-17A Induces Eotaxin-1/CC Chemokine Ligand 11 Expression in Human Airway Smooth Muscle Cells: Role of MAPK (Erk1/2, JNK, and p38) Pathways
J. Immunol.,
September 15, 2006;
177(6):
4064 - 4071.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Komiyama, S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura
IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis
J. Immunol.,
July 1, 2006;
177(1):
566 - 573.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Lajoie-Kadoch, P. Joubert, S. Letuve, A. J. Halayko, J. G. Martin, A. Soussi-Gounni, and Q. Hamid
TNF-{alpha} and IFN-{gamma} inversely modulate expression of the IL-17E receptor in airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol,
June 1, 2006;
290(6):
L1238 - L1246.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Fallon, S. J. Ballantyne, N. E. Mangan, J. L. Barlow, A. Dasvarma, D. R. Hewett, A. McIlgorm, H. E. Jolin, and A. N.J. McKenzie
Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion
J. Exp. Med.,
April 17, 2006;
203(4):
1105 - 1116.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. C. Jenmalm, H. Cherwinski, E. P. Bowman, J. H. Phillips, and J. D. Sedgwick
Regulation of Myeloid Cell Function through the CD200 Receptor
J. Immunol.,
January 1, 2006;
176(1):
191 - 199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ishizu, M. Osoegawa, F.-J. Mei, H. Kikuchi, M. Tanaka, Y. Takakura, M. Minohara, H. Murai, F. Mihara, T. Taniwaki, et al.
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
Brain,
May 1, 2005;
128(5):
988 - 1002.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. L. Langrish, Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
J. Exp. Med.,
January 18, 2005;
201(2):
233 - 240.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. K. Liu, X. Lin, and S. L. Gaffen
Crucial Role for Nuclear Factor of Activated T Cells in T Cell Receptor-mediated Regulation of Human Interleukin-17
J. Biol. Chem.,
December 10, 2004;
279(50):
52762 - 52771.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Andersson, R. Kokkola, J. Wefer, H. Erlandsson-Harris, and R. A. Harris
Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility
J. Leukoc. Biol.,
December 1, 2004;
76(6):
1118 - 1124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Lieberman, F. Cardillo, A. M. Owyang, D. M. Rennick, D. J. Cua, R. A. Kastelein, and C. A. Hunter
IL-23 Provides a Limited Mechanism of Resistance to Acute Toxoplasmosis in the Absence of IL-12
J. Immunol.,
August 1, 2004;
173(3):
1887 - 1893.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Ruddy, G. C. Wong, X. K. Liu, H. Yamamoto, S. Kasayama, K. L. Kirkwood, and S. L. Gaffen
Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-{alpha} Is Mediated by CCAAT/Enhancer-binding Protein Family Members
J. Biol. Chem.,
January 23, 2004;
279(4):
2559 - 2567.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nakae, A. Nambu, K. Sudo, and Y. Iwakura
Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice
J. Immunol.,
December 1, 2003;
171(11):
6173 - 6177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R.-B. Yang, C. K. D. Ng, S. M. Wasserman, L. G. Komuves, M. E. Gerritsen, and J. N. Topper
A Novel Interleukin-17 Receptor-like Protein Identified in Human Umbilical Vein Endothelial Cells Antagonizes Basic Fibroblast Growth Factor-induced Signaling
J. Biol. Chem.,
August 29, 2003;
278(35):
33232 - 33238.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. W. Hellings, A. Kasran, Z. Liu, P. Vandekerckhove, A. Wuyts, L. Overbergh, C. Mathieu, and J. L. Ceuppens
Interleukin-17 Orchestrates the Granulocyte Influx into Airways after Allergen Inhalation in a Mouse Model of Allergic Asthma
Am. J. Respir. Cell Mol. Biol.,
January 1, 2003;
28(1):
42 - 50.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S Fujino, A Andoh, S Bamba, A Ogawa, K Hata, Y Araki, T Bamba, and Y Fujiyama
Increased expression of interleukin 17 in inflammatory bowel disease
Gut,
January 1, 2003;
52(1):
65 - 70.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Kim, R. Manoukian, R. Yeh, S. M. Silbiger, D. M. Danilenko, S. Scully, J. Sun, M. L. DeRose, M. Stolina, D. Chang, et al.
Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production
Blood,
September 18, 2002;
100(7):
2330 - 2340.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Benchetrit, A. Ciree, V. Vives, G. Warnier, A. Gey, C. Sautes-Fridman, F. Fossiez, N. Haicheur, W. H. Fridman, and E. Tartour
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism
Blood,
March 15, 2002;
99(6):
2114 - 2121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Haudenschild, T. Moseley, L. Rose, and A. H. Reddi
Soluble and Transmembrane Isoforms of Novel Interleukin-17 Receptor-like Protein by RNA Splicing and Expression in Prostate Cancer
J. Biol. Chem.,
February 1, 2002;
277(6):
4309 - 4316.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Starnes, M. J. Robertson, G. Sledge, S. Kelich, H. Nakshatri, H. E. Broxmeyer, and R. Hromas
Cutting Edge: IL-17F, a Novel Cytokine Selectively Expressed in Activated T Cells and Monocytes, Regulates Angiogenesis and Endothelial Cell Cytokine Production
J. Immunol.,
October 15, 2001;
167(8):
4137 - 4140.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Infante-Duarte, H. F. Horton, M. C. Byrne, and T. Kamradt
Microbial Lipopeptides Induce the Production of IL-17 in Th Cells
J. Immunol.,
December 1, 2000;
165(11):
6107 - 6115.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Li, J. Chen, A. Huang, J. Stinson, S. Heldens, J. Foster, P. Dowd, A. L. Gurney, and W. I. Wood
Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family
PNAS,
January 18, 2000;
97(2):
773 - 778.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Lee, W.-H. Ho, M. Maruoka, R. T. Corpuz, D. T. Baldwin, J. S. Foster, A. D. Goddard, D. G. Yansura, R. L. Vandlen, W. I. Wood, et al.
IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1
J. Biol. Chem.,
January 5, 2001;
276(2):
1660 - 1664.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Shi, S. J. Ullrich, J. Zhang, K. Connolly, K. J. Grzegorzewski, M. C. Barber, W. Wang, K. Wathen, V. Hodge, C. L. Fisher, et al.
A Novel Cytokine Receptor-Ligand Pair. IDENTIFICATION, MOLECULAR CHARACTERIZATION, AND IN VIVO IMMUNOMODULATORY ACTIVITY
J. Biol. Chem.,
June 16, 2000;
275(25):
19167 - 19176.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
